GLRA
ALXN

Gerald L. Ray & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Gerald L. Ray & Associates’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,500
Closed -$306K – 321
2016
Q4 		$306K Buy
+2,500
New +$306K 0.04% 255